U.S. Court in DC Tosses Hospitals’ Challenge to Drug Manufacturer 340B Audits
- June 20, 2025
The Health Resources and Services Administration’s (HRSA’s) approval of drug manufacturer Johnson & Johnson’s (J&J’s) plans to audit five hospitals for compliance with 340B eligibility requirements was not reviewable final agency action, the U.S. District Court for the District of Columbia held June 18.
ARTICLE TAGS
You must be logged in to access this content.